The BusinessWeek 50 Ranking
26
Johnson & Johnson
In a year when its drug company rivals were stumbling, Johnson & Johnson continued to prosper. Its broad portfolio of businesses offset weakness in one market with strength in other lines. So while J&J's franchise in drug-coated cardiac stents and its blockbuster anemia drug Procrit lost steam to new competition, other prescription drugs and medical devices helped fuel an 18% increase in net income. The New Brunswick (N.J.) company's deep pockets came in handy: In late 2004, J&J struck a $24 billion deal to acquire cardiac-device maker Guidant Corp.
Company Info
| 2004 Rank | 24 |
| STOCK INFO | JNJ |
| Market Value | $194.7 BILLION |
| Total Return | (1-yr.) 24.0%
(3-yr.) 13.5% |
| 2004 sales | $47.3 BILLION |
| Sales Growth | (1-yr.) 13%
(3-yr.) 13.8% |
| Net income | $8.5 BILLION |
| Net Income Growth | (1-yr.) 18%
(3-yr.) 14.0% |
| Net Margin* | 18.0% |
| Return on Equity* | 27.0% |
| Industry | DRUGS & BIOTECH |
| CORPORATE WEB SITE | |
More in S&P 500 Companies Scoreboard >
*Trailing 12 months
Company data as of 2/28/05 provided by Standard & Poor's Compustat
J&J: Don't Stop Dealmaking Now
Rewiring the Body
Health Care's Mixed Signals
Why Boston Scientific Is Pumping Again
Investing to Fight Disease
Company Snapshot
Johnson & Johnson engages in the manufacture and sale of various products in the health care field primarily in the United States. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment manufactures and markets various products used in the baby and child care, skin care, oral and wound care, and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products. These products are marketed principally to the general public, and sold to wholesalers and directly to independent and chain retail outlets worldwide. The Pharmaceutical segment provides various products in the antifungal, anti-infective, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, psychotropic, and urology fields. These products are distributed both directly and through wholesalers and health care professionals for use by prescription by the general public. The Medical Devices and Diagnostics segment includes various products, such as wound care and women's health products, minimally invasive surgical products, circulatory disease management products, blood glucose monitoring products, professional diagnostic products, orthopaedic joint reconstruction and spinal products, and disposable contact lenses. These products are distributed through surgical supply and other dealers to physicians, nurses, therapists, hospitals, diagnostic laboratories, and clinics. The company also operates in Europe, Africa, Asia, and Pacific. Johnson & Johnson was founded in 1887 by Robert Wood Johnson and is headquartered in New Brunswick, New Jersey.
No. of Employees
109,900
Data provided by